Celyad Oncology S.A.
CYAD.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €4 | €7 | €12 | €30 |
| Short-Term Investments | €0 | €0 | €0 | €0 |
| Receivables | €1 | €0 | €1 | €2 |
| Inventory | €0 | €1 | €0 | €0 |
| Other Curr. Assets | €1 | €2 | €1 | €2 |
| Total Curr. Assets | €7 | €11 | €15 | €34 |
| Property Plant & Equip (Net) | €1 | €2 | €0 | €3 |
| Goodwill | €0 | €0 | €0 | €1 |
| Intangibles | €0 | €0 | €1 | €35 |
| Long-Term Investments | €1 | €3 | €0 | €2 |
| Tax Assets | €0 | €0 | €0 | -€2 |
| Other NC Assets | €0 | €0 | €4 | €6 |
| Total NC Assets | €3 | €5 | €5 | €46 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €10 | €16 | €20 | €80 |
| Liabilities | – | – | – | – |
| Payables | €1 | €1 | €5 | €7 |
| Short-Term Debt | €0 | €0 | €0 | €2 |
| Tax Payable | €0 | €0 | €0 | €0 |
| Deferred Revenue | €1 | €0 | €1 | €1 |
| Other Curr. Liab. | €1 | €2 | €4 | €4 |
| Total Curr. Liab. | €3 | €3 | €10 | €14 |
| LT Debt | €17 | €1 | €0 | -€13 |
| Deferred Rev, NC | €4 | €5 | €5 | €6 |
| Deferred Tax Liab, NC | €0 | €0 | €0 | €15 |
| Other NC Liab. | €2 | €2 | €0 | €15 |
| Total NC Liab. | €23 | €24 | €5 | €22 |
| Other Liabilities | €0 | -€17 | €0 | €0 |
| Cap. Leases | €1 | €1 | €0 | €3 |
| Total Liabilities | €26 | €10 | €15 | €36 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €0 | €0 |
| Common Stock | €8 | €33 | €79 | €79 |
| Retained Earnings | -€364 | -€358 | -€350 | -€309 |
| AOCI | €340 | €332 | €269 | €268 |
| Other Equity | €0 | €0 | €6 | €6 |
| Total Equity | -€16 | €6 | €4 | €44 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €10 | €16 | €20 | €80 |
| Net Debt | €13 | -€6 | -€12 | -€41 |